Show Cart
PipelineReview.com
Home
My cart / Checkout
Contact Us
Home
News Channels
Antibodies
DNA, RNA & Cells
Protein & Peptides
Small Molecules
Vaccines
More News
Reports
All Products
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells & NK Cells
Immuno-Oncology
mRNA Vaccines & Therapeutics
Pipeline Database
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Proteins & Peptides
Vaccines
FREE reports
Offers
Press Room
About Us
Home
News Channels
Antibodies
DNA, RNA & Cells
Protein & Peptides
Small Molecules
Vaccines
More News
Reports
All Products
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells & NK Cells
Immuno-Oncology
mRNA Vaccines & Therapeutics
Pipeline Database
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Proteins & Peptides
Vaccines
FREE reports
Offers
Press Room
About Us
Home
News Channels
News Channels
04 Feb 2019
VLP Therapeutics to Initiate First Clinical Trial of VLPM01 Malaria Vaccine
04 Feb 2019
GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)
04 Feb 2019
Alkermes Receives Complete Response Letter From U.S. Food and Drug Administration for ALKS 5461 New Drug Application
04 Feb 2019
European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
04 Feb 2019
argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology
04 Feb 2019
Eisai and Purdue Pharma Present Efficacy and Safety Data from Second Pivotal Phase 3 Study at the Sleep Research Society’s Conference: Advances in Sleep and Circadian Science
04 Feb 2019
CHMP recommends approval of Praluent® (alirocumab) to reduce cardiovascular risk in people with established atherosclerotic cardiovascular disease
03 Feb 2019
Evolus Receives FDA Approval for Jeuveau™ prabotulinumtoxinA-xvfs for Injection
02 Feb 2019
Pfizer Receives Positive CHMP Opinion for Vizimpro® (dacomitinib) for the First-line Treatment of Adult Patients with Locally Advanced Or Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations
02 Feb 2019
Teva Receives Positive Committee for Medicinal Products for Human Use (CHMP) Opinion for AJOVY® (fremanezumab) for the Prophylaxis of Migraine in Adults
01 Feb 2019
Achillion Announces First Dosing in Phase 1 Multiple Ascending Dose Study of ACH-5228 Next-Generation Oral Factor D Inhibitor in Healthy Volunteers
01 Feb 2019
FDA Expands Lilly's ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer
01 Feb 2019
Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
01 Feb 2019
Alexion and Caelum Biosciences Announce Collaboration to Develop Targeted Therapy for Light Chain (AL) Amyloidosis
01 Feb 2019
Invenra and WARF Initiate a Collaboration to Discover and Develop Novel Therapeutics to Fight Neuroblastoma in Children
01 Feb 2019
Hua Medicine Initiates First Combination Study of Dorzagliatin with a DPP-4 Inhibitor in the United States
01 Feb 2019
OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator
31 Jan 2019
Cullinan Oncology to Develop Novel EBNA1 Inhibitor Discovered by The Wistar Institute
31 Jan 2019
Newly Published Pre-Clinical Data Show Intratumoral Injections of Messenger RNA Encoding Three Immune Modulators Stimulate Durable Anti-Cancer Responses in Treated and Distal Tumors
31 Jan 2019
Repare Therapeutics Announces a Strategic Partnership Agreement With ONO Pharmaceutical Co., Ltd. for Repare’s Polθ Inhibitor Program in Japan and Selected Territories in Asia
Page 6 of 2228
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Currencies
Australian dollar $
British pound £
Canadian dollar $
Danish krone kr
Euro €
Japanese yen ¥
Swedish krona kr
Swiss franc CHF
United States dollar $
Shopping cart
Cart empty
Please wait
Latest report
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β, CXCR4, CSF-1R, CD47-SIRPα, adenosine pathway & STING 2018
Featured Products
Report Package: TCR-Based Antibody and T-Cell Immunotherapy
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends
Latest Target Pipeline
Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018
Currencies
Australian dollar $
British pound £
Canadian dollar $
Danish krone kr
Euro €
Japanese yen ¥
Swedish krona kr
Swiss franc CHF
United States dollar $
Shopping cart
Cart empty
Please wait
Latest report
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β, CXCR4, CSF-1R, CD47-SIRPα, adenosine pathway & STING 2018
Featured Products
Report Package: TCR-Based Antibody and T-Cell Immunotherapy
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends
Latest Target Pipeline
Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018
La Merie Biologics
FREE Weekly News Bulletin
Sign Up
2017 Sales of
Antibodies & Proteins
Get it now
New Product Alert
For La Merie Publishing
Sign Up
Top